Starpharma Holdings Limited (SPL.AX)
AUD 0.1
(3.09%)
AUD 0.1
(3.09%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 8.28 Million | 2.93 Million | 4.68 Million | 1.79 Million | 6.03 Million | 2.72 Million |
| Cost of Revenue | 632 Thousand | 1.71 Million | 2.77 Million | 1.25 Million | 1.8 Million | 251 Thousand |
| Gross Profit | 7.65 Million | 1.22 Million | 1.9 Million | 539.5 Thousand | 4.23 Million | 2.46 Million |
| Operating Expenses | 22.81 Million | 25.89 Million | 25.8 Million | 29.2 Million | 25.66 Million | 16.72 Million |
| Selling, General and Administrative Expenses | 3.57 Million | 7.02 Million | 6.86 Million | 6.88 Million | 5.18 Million | 6.26 Million |
| Research and Development Expenses | 15.58 Million | 18.87 Million | 18.94 Million | 22.32 Million | 20.47 Million | 15.52 Million |
| Other Expenses | - | 135 Thousand | 263 Thousand | 1.33 Million | 559 Thousand | 12 Thousand |
| Cost and Expenses | 23.44 Million | 27.61 Million | 28.57 Million | 30.46 Million | 27.46 Million | 16.97 Million |
| Operating Income | -15.15 Million | -24.67 Million | -23.89 Million | -28.66 Million | -21.42 Million | -14.25 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -5.52 Million | -7.63 Million | -7.26 Million | -7.24 Million | -5.66 Million | -5.07 Million |
| Earnings before Tax | -13.69 Million | -23.26 Million | -23.41 Million | -26.98 Million | -20.34 Million | -14.25 Million |
| Net Income | -8.16 Million | -15.63 Million | -16.15 Million | -19.73 Million | -14.67 Million | -14.25 Million |
| Earnings Per Share Basic | -0.02 | -0.04 | -0.04 | -0.05 | -0.04 | -0.04 |
| Earnings Per Share Diluted | -0.02 | -0.04 | -0.04 | -0.05 | -0.04 | -0.04 |
| Weighted Average Shares Outstanding | 411.43 Million | 390.95 Million | 403.85 Million | 394.64 Million | 366.95 Million | 356.35 Million |
| Weighted Average Shares Outstanding (Diluted) | 411.43 Million | 409.03 Million | 406.9 Million | 396.87 Million | 372.23 Million | 371.29 Million |
| Gross Margin | 0.92 | 0.42 | 0.41 | 0.30 | 0.70 | 0.91 |
| EBIT Margin | -1.52 | -7.99 | -4.87 | -15.42 | -3.40 | -5.13 |
| Profit Margin | -0.99 | -5.32 | -3.45 | -10.97 | -2.43 | -5.24 |
| EBITDA | -12.57 Million | -15.24 Million | -15.79 Million | -21.42 Million | -14.4 Million | -13.95 Million |
| Earnings Before Tax Margin | -1.83 | -8.40 | -5.10 | -15.94 | -3.55 | -5.24 |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.73 Million | 8.28 Million | 7.19 Million | 1.85 Million | 2.93 Million | 1.08 Million |
| Cost of Revenue | 5.22 Million | 1.18 Million | 770 Thousand | 868 Thousand | 1.71 Million | 1.15 Million |
| Gross Profit | -3.49 Million | 7.09 Million | 6.42 Million | 985 Thousand | 1.22 Million | -69 Thousand |
| Operating Expenses | 10.86 Million | 22.25 Million | 11.38 Million | 12.45 Million | 25.89 Million | 13.13 Million |
| Selling, General and Administrative Expenses | 3.64 Million | - | 3.02 Million | 3.48 Million | - | 3.23 Million |
| Research and Development Expenses | 7.22 Million | - | 8.35 Million | 8.96 Million | - | 9.9 Million |
| Other Expenses | - | - | - | - | 135 Thousand | - |
| Cost and Expenses | 16.08 Million | 23.44 Million | 12.15 Million | 13.31 Million | 27.61 Million | 14.29 Million |
| Operating Income | -14.35 Million | -15.15 Million | -4.95 Million | -11.46 Million | -24.67 Million | -13.2 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -2.43 Million | -5.52 Million | -3.09 Million | -3.32 Million | -7.63 Million | -4.3 Million |
| Earnings before Tax | -7.13 Million | -13.69 Million | -4.12 Million | -10.68 Million | -23.26 Million | -12.58 Million |
| Net Income | -7.13 Million | -8.16 Million | -1.03 Million | -7.36 Million | -15.63 Million | -8.27 Million |
| Earnings Per Share Basic | -0.02 | - | -0.00 | -0.02 | - | -0.02 |
| Earnings Per Share Diluted | -0.02 | - | -0.00 | -0.02 | - | -0.02 |
| Weighted Average Shares Outstanding | 407.97 Million | 411.43 Million | 410.86 Million | 409.53 Million | 390.95 Million | 408.58 Million |
| Weighted Average Shares Outstanding (Diluted) | 412 Million | 411.43 Million | 410.86 Million | 409.53 Million | 409.03 Million | 408.58 Million |
| Gross Margin | -2.02 | 0.86 | 0.89 | 0.53 | 0.42 | -0.06 |
| EBIT Margin | -4.03 | - | -0.61 | -5.87 | - | -11.60 |
| Profit Margin | -4.12 | -0.99 | -0.14 | -3.97 | -5.32 | -7.62 |
| EBITDA | -6.98 Million | - | -4.38 Million | -10.88 Million | - | -12.59 Million |
| Earnings Before Tax Margin | -8.29 | -1.83 | -0.69 | -6.19 | -8.40 | -12.16 |
STT
1TT
PET
GLOP-PA
SAVE
DIB